(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6diazabicyclo[3.2.0]heptane

Details for Australian Patent Application No. 2005275387 (hide)

Owner Abbott Laboratories

Inventors Kotecki, Brian J.; Ji, Jianguo; Li, Wenke; Hannick, Steven M.; Zhang, Geoff G.; Wayne, Greg S.; Robbins, Timothy A.; Buckley, Michael J.; Wang, Weili W.; Wittenberger, Steven J.; Henry, Rodger F.; Marci, Bryan S.; Towne, Timothy B.

Agent Spruson & Ferguson

Pub. Number AU-B-2005275387

PCT Pub. Number WO2006/019660

Priority 10/898,441 23.07.04 US

Filing date 8 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 10 November 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4439 (2006.01)

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019660 Priority application(s): WO2006/019660

10 November 2011 Application Accepted

  Published as AU-B-2005275387

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275399-Organ devices having a fiber structure

2005275374-Compression connector for coaxial cable